A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis (NCT03332225) | Clinical Trial Compass
CompletedPhase 2
A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
Greece36 participantsStarted 2017-12-15
Plain-language summary
The aim of the study is to conduct one RCT of personalized immunotherapy in sepsis targeting patients who lie either on the predominantly hyper-inflammatory arm or on the predominantly hypo-inflammatory arm of the spectrum of the host response. These patients will be selected by the use of a panel of biomarkers and laboratory findings and they will be randomly allocated to placebo or immunotherapy treatment according to their needs.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age equal to or above 18 years
* Male or female gender
* In case of women, unwillingness to remain pregnant during the study period
* Written informed consent provided by the patient or by one first-degree relative/spouse in case of patients unable to consent
* Community-acquired pneumonia or hospital-acquired pneumonia or ventilator-associated pneumonia or primary bacteremia or acute cholangitis
* Sepsis defined by the Sepsis-3 definitions.
* Patients with laboratory diagnosis of MALS or hypo-inflammation (immune-paralysis) based on two consecutive blood sampling with 24 hours apart. MALS is defined as the presence of ferritin \>4,420 ng/ml and hypo-inflammation as HLA-DR expression on CD14-monocytes (co-expression) less than 30%
Exclusion Criteria:
* Age below 18 years
* Denial for written informed consent
* Acute pyelonephritis or intraabdominal infection other than AC, meningitis or skin infection. It is explicitly stated that in the case of a patient with both AC and any other type of intraabdominal infection, the patient cannot be enrolled.
* Any stage IV malignancy
* Any do not resuscitate decision
* In the case of BSI, patients with blood cultures growing coagulase-negative staphylococci or skin commensals or catheter-related infections cannot be enrolled.
* Active tuberculosis (TB) as defined by the co-administration of drugs for the treatment of TB
* Infection by the human immunodeficiency virus (HIV)
* Any primary immunodeficiency
* Oral or…